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Abstract
Aim: To evaluate the effect of cigarette smoking on periodontal health at patient,
tooth, and site levels following supportive therapy.
Materials and Methods: Eighty chronic periodontitis patients, 40 smokers and 40
non-smokers, were recruited to a single-arm clinical trial. Periodontal examina-
tions were performed at baseline (T0), 3 months following active periodontal
therapy (T1), and 12 months following supportive periodontal therapy (T2).
Smoking status was validated measuring serum cotinine levels. Probing depth
(PD) ≥ 5 mm with bleeding on probing (BoP) was defined as the primary out-
come. Logistic regression analyses adjusted for clustered observations of patients,
teeth, and sites and mixed effects models were employed to analyse the data.
Results: All clinical parameters improved from T0 to T2 (p < 0.001), whereas
PD, bleeding index (BI), and plaque index (PI) increased from T1 to T2 in smok-
ers and non-smokers (p < 0.001). An overall negative effect of smoking was
revealed at T2 (OR = 2.78, CI: 1.49, 5.18, p < 0.001), with the most pronounced
effect at maxillary single-rooted teeth (OR = 5.08, CI: 2.01, 12.78, p < 0.001). At
the patient level, less variation in treatment outcome was detected within smokers
(ICC = 0.137) compared with non-smokers (ICC = 0.051).
Conclusion: Smoking has a negative effect on periodontal health following
12 months of supportive therapy, in particular at maxillary single-rooted teeth.
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Active periodontal therapy (APT)
followed by supportive periodontal
therapy (SPT) has been demon-
strated successful in a majority of
patients (Axelsson & Lindhe 1981,
Ramfjord 1987, Rosling et al. 2001,
Axelsson et al. 2004). In perspective,
patients susceptible to recurrence of
periodontal disease have been
offered SPT at 3- to 4-month inter-
vals with the intent to maintain
treatment outcomes following APT,
whereas less susceptible patients may
be well served, using a less frequent
SPT interval (Knowles et al. 1979,
Lindhe & Nyman 1984). To facilitate
identification of individuals at high
risk for disease progression, a func-
tional Periodontal Risk Assessment
(PRA) diagram has been proposed
(Lang & Tonetti 2003). In a longitu-
dinal study validating the PRA
model, patients allocated to the
high-risk category following APT
showed a higher incidence of tooth
loss compared with moderate- or
low-risk patients (Eickholz et al.
2008).
In spite of clinical benefits, only a
minority of patients appear to com-
ply with recommended SPT regimens
(Checchi et al. 1994, Demetriou
et al. 1995), and efforts to optimize
compliance being only partly suc-
cessful (Wilson et al. 1993). Further,
it appears that SPT compliance
decreases as the risk profile of the
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subject increases (Mendoza et al.
1991, Matuliene et al. 2010). Because
of imperfect outcomes following
APT (Bunæs et al. 2015) and incon-
sistent compliance (Matuliene et al.
2010, Ramseier et al. 2014), the
selection of appropriate SPT inter-
vals is of paramount importance for
the maintenance of periodontal sta-
bility in cigarette smokers.
Smoking is a critical patient-
related risk factor for chronic peri-
odontitis and smokers exhibit fewer
teeth and more advanced periodon-
tal attachment loss compared with
non-smokers (Kerdvongbundit &
Wikesjo 2000, Calsina et al. 2002,
Jansson & Lavstedt 2002). High
cigarette consumption amplifies clini-
cal manifestations of chronic peri-
odontal disease and demands
increased treatment needs (Dietrich
et al. 2004, Susin et al. 2004, Do
et al. 2008, Ramseier et al. 2015).
Based on subjectively reported pack-
year consumption, dose-dependent
impaired clinical outcomes following
SPT have been reported (Kaldahl
et al. 1996a). It is unclear to what
extent treatment response is influ-
enced by a cumulative impact of
smoking over years or by the con-
sumption during SPT. However, a
positive effect of smoking cessation
on periodontal treatment outcomes
may indicate the effect of present
smoking exposure (Preshaw et al.
2005, Rosa et al. 2011).
Generally, optimal soft and hard
tissue healing following APT is a
critical point for successful treatment
outcome. In a recently published
study, Bunæs et al. (2015) reported
impaired site-specific tissue responses
to non-surgical and surgical APT in
smokers compared with non-smo-
kers. The multilevel approach using
probing depth (PD) with bleeding on
probing (BoP) as the primary out-
come variable showed that plaque
positive sites increased the risk for
unfavourable treatment outcomes in
smokers. A local additive detrimen-
tal effect of smoking is supported by
studies reporting increased incidence
of oral cancer and altered composi-
tion of the oral biofilm (Haffajee &
Socransky 2001, Hashibe et al. 2007,
Guglielmetti et al. 2014).
Longitudinal cohort studies have
reported that smoking 20 or more
cigarettes a day increased the risk of
disease progression following APT
(Kaldahl et al. 1996a, Matuliene
et al. 2008). In contrast, long-term
follow-up studies have not found an
association between smoking status
and tooth loss (Fisher et al. 2008,
Saminsky et al. 2015). These incon-
clusive findings indicate that the
effect of subjectively reported smok-
ing habits on the outcome of SPT
needs to be addressed in a prospec-
tive study with an objective measure
of smoking exposure.
To the best of our knowledge,
there seems to be no prospective
studies evaluating the patient, tooth,
and site-related effects of cigarette
smoking on the outcome of SPT in
chronic periodontitis patients, using
an objective measure of smoking sta-
tus. Thus, the specific aims of this
study were to determine the effect of
smoking at patient, tooth, and site
levels following 12 months of SPT
and to compare the predictive value
of clinical parameters for the out-
come of SPT in smokers and non-
smokers.
Material and Methods
The study protocol and informed
consent approved by the Institu-
tional Medical Research Ethics
Committee (2011/151-6), University
of Bergen, Norway, followed the
Helsinki Declaration of 1975, ver-
sion 2008. Participating subjects read
and signed the informed consent
prior to inclusion in the study.
Pre-study tests
Two pre-study exercises were per-
formed. First, the intra-examiner
(DFB) reproducibility was tested by
measuring PD and clinical attach-
ment levels (CAL) twice at six sites
per tooth in 10 patients. Intra-class
correlation coefficients (ICC) for
repeated measures ranged between
0.92 and 0.96 for PD and between
0.93 and 0.96 for CAL. The sample
size estimation was based on change
in PD. A difference of 0.5 mm was
considered clinically relevant. Stan-
dard deviation of the differences
between repeated PD measurements
from the intra-calibration amounted
to 0.5 mm. A power analysis based
on 40 subjects per group and with
the level of significance (a) set to
0.05, gave an 88% power to detect a
true difference of 0.5 mm. Second,
masking of the operator (DFB)
towards smoking status was tested in
30 chronic periodontitis patients.
Twenty-eight of 30 patients (93%)
were correctly identified as smokers
or non-smokers (p < 0.001; for detail
see Bunæs et al. 2015).
Eligibility criteria, patient sample, and
smoking status
Inclusion criteria were healthy sub-
jects aged 35–75 years, none using
medication that could affect peri-
odontal healing, having at least four
non-adjacent teeth with an inter-
proximal PD ≥ 6 mm and clinical
attachment loss ≥5 mm with BoP
without signs of apical pathology
(Tonetti & Claffey 2005, Page & Eke
2007). The patients were either
smokers (>10 cigarettes/day for at
least 5 years) or non-smokers (never
or not smoked within the last
5 years). Patients starting or discon-
tinuing smoking during the study
were not excluded. Exclusion criteria
included any current medical condi-
tion affecting periodontal treatment,
use of systemic antibiotics or subgin-
gival scaling within 6 months prior
initiation of the study, and delay of
scheduled treatment visits by more
than one month.
Eighty patients, 40 smokers and
40 non-smokers, with moderate to
severe chronic periodontitis (Armi-
tage 1999) referred for periodontal
treatment from general practitioners
in a rural district of Norway were
consecutively enroled in this single-
arm clinical trial March 2012 through
September 2013 (Table 1). Medical,
periodontal, and smoking history of
the patients was obtained from clini-
cal examinations, health forms, ques-
tionnaires, and by consulting their
physicians. All referred patients were
examined for eligibility and consecu-
tively invited to participate.
The subjectively reported smoking
status was calculated in pack years;
the number of cigarettes smoked daily
multiplied by the number of years
divided by 20 (a standard pack of
cigarettes) (Scott et al. 2001). Before
and at the end of the study, smoking
status was objectively validated by
measuring cotinine levels in serum.
Peripheral venous blood was collected
from each participant using a glass
vacutainer. After coagulation, blood
was centrifuged (700 9 g for 10 min.)
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and the serum was stored in aliquots
at 80°C. Serum cotinine was
assessed according to the instructions
of the serum enzyme immunoassay
kit (Cotinine ELISA Kit; MyBio-
Source, San Diego, CA, USA) mea-
suring the absorbance at 450 nm with
a microplate reader (FluoStar Optima
V1.32 R2; BMG Labtech, Offenburg,
Germany).
Clinical assessments
A full-mouth intra-oral radiographs
series was recorded before the clinical
examination. Clinical recordings were
collected at baseline pre-ATP (T0), at
3 months post-APT (T1), and follow-
ing 12 months of SPT (T2). PD was
recorded as the distance from the gin-
gival margin to the probeable base of
the pocket, CAL as the distance from
the cemento-enamel junction or the
margin of a dental restoration to the
probeable base of the pocket. PD and
CAL were measured using a periodon-
tal probe (PCPUNC 15; Hu-Friedy,
Chicago, IL, USA) at six sites per
tooth rounding up to the nearest mm.
Full mouth gingival bleeding scores
were recorded as the percentage of
sites showing bleeding on gentle prob-
ing (Ainamo & Bay, 1975) and full
mouth dental plaque scores as the per-
centage of tooth surfaces with visible
plaque following staining with disclos-
ing solution (O’Leary et al. 1972). As
a supplement to staining, the peri-
odontal probe was used to discrimi-
nate between plaque and pellicle.
Treatment
APT (T0-T1) and SPT (T1-T2) were
performed by the same operator
(DFB). APT included nonsurgical
and surgical periodontal therapy
individualized to optimize treatment
outcomes for each patient. Follow-
ing ATP, a programme with regular
appointments every three months
was scheduled for SPT (Knowles
et al. 1979, Lindhe et al. 1984). The
60-min appointments included
re-motivation and re-instruction in
oral hygiene, full mouth plaque
removal, and supra- and subgingival
debridement as needed. In addition,
smokers were motivated to reduce or
quit smoking, and encouraged to
participate in a public smoking ces-
sation programme (Røyketelefonen,
Helsedirektoratet, Oslo, Norway).
Mechanical debridement was carried
out using conventional hand-instru-
ments (Hu-Friedy, Chicago, IL,
USA; and American Eagle Instru-
ments, Missoula, MT, USA) and
ultrasonic scalers (EMS, Nyon,
Switzerland). For plaque removal,
rotating rubber cups and glycine
powder (EMS – Air Flow-Perio) in
an air-polishing device (Dentsply
Prophy-Jet ; Dentsply, York, PA,
USA) were used.
Statistical analysis
The Shapiro–Wilk test was used to
check for the assumption of normal
distributed data. According to the
test, the data were considered nor-
mally distributed. Means and stan-
dard deviations of secondary
outcome variables (number of teeth,
PD, CAL, BI, PI) were calculated
and differences were tested, using the
two sample t-test and Mann–Whit-
ney test. Chi-square test was applied
for testing of differences in frequen-
cies and percentages between the cat-
egorical variables.
In an adjusted logistic regression
model, gender was categorized as
male (1) and female (0), age as
≥60 years (1) and ˂60 years (0), self-
reported education as ≤9 years (1)
and >9 years (0), and marital status
as married/cohabitant (1) and living
alone (0). The primary outcome vari-
able PD ≥ 5 mm with BoP was
dichotomized as (1) present and (0)
absent. Each site, corrected for clus-
tering of data within teeth and
patients, was the unit of analysis.
Sites presenting PD ≥ 5 mm with
BoP at teeth extracted between T0
and T1 were not included in the
analysis. Associations between
PD ≥ 5 mm with BoP at T2 and
clinical variables at T0 and T1 were
tested using adjusted logistic regres-
sion analysis. Plaque positive sites
categorized as (0) and plaque nega-
tive sites as (1), BoP positive sites as
(0) and BoP negative sites as (1),
and overall mean values calculated
at T0 and T1 for PD and CAL were
tested. For the smoking effect model
following T1, specific teeth and sites
were tested at T1 and T2. Two
dummy variables were made for time
and smoke and included in the
adjusted model: (T2 = 1 and Smoke
= 0) as (1) and (T2 = 1 and Smoke =
1) as (0) and (T1 = 1 and Smoke =
0) as (1) and T1 = 1 and Smoke = 1)
as (0). Intra-class correlation coeffi-
cients (ICC) within patients, teeth,
and sites were calculated using linear
mixed effects models.
Odds ratios (OR) and 95% confi-
dence intervals (95% CI) were calcu-
lated. A p-value <0.05 was
considered statistically significant.
All analyses were conducted using
Stata version 13 (Stata Corp., Col-
lege Station, TX, USA).
Results
Eighty patients, 40 smokers (mean
age 57.6 years, range 37–70 years)
and 40 non-smokers (mean age
58.7 years, range 35–73 years),
entered this study. Socio-demo-
graphic characteristics according to
smoking status at baseline (T0) are
summarized in Table 1. The experi-
mental protocol started April 2012
to end March 2015. Thirty-six (90%)
smokers and 36 (90%) non-smokers
completed the study (Fig. 1). Drop-
outs did not alter the socio-demo-
graphic characteristics at T1 and T2.







≥60 years/<60 years 21/19 (52.5/47.5) 22/18 (55.0/45.0) 0.096
Male/female 15/25 (37.5/62.5) 23/17 (56.0/44.0) 0.121
Cohabitant/single 24/16 (60.0/40.0) 35/5 (87.2/12.8) 0.011
Elementary school/education beyond 30/10 (75.0/25.0) 20/20 (50.0/50.0) 0.025
Working/not working 18/22 (45.0/55.0) 28/12 (70.0/30.0) 0.069
Satisfaction/dissatisfaction with oral
health
10/28 (26.3/73.7) 7/32 (18.0/82.1) 0.376
Alcohol consumption daily or weekly/
monthly or never
21/25 (58.3/41.7) 18/21 (46.2/53.9) 0.292
Dental visits regularly/irregularly 35/2 (94.6/5.4) 37/2 (94.9/5.1) 0.957
Students t-test and Chi-square: p-level <0.05.
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Three (7.9%) smokers reported dis-
continuing smoking between T1 and
T2, only one exhibited a cotinine




higher mean PD and CAL at all
time-points (Table 2). Between T0
and T2 both groups responded
favourable to periodontal therapy
with significant reductions in mean
PD, CAL, BI, and PI (p < 0.001)
(not tabulated). However, during
SPT, from T1 to T2, mean PD, BI,
and PI increased in both groups. In
smokers mean PD increased from
2.63 to 2.80 mm (p = 0.007) and in
non-smokers from 2.27 to 2.42 mm
(p = 0.002), BI in smokers from
22.42 to 27.00 (p = 0.011) and in
non-smokers from 22.81 to 30.50
(p = 0.001), and PI in smokers from
18.45 to 30.09 (p < 0.001) and in
non-smokers from 21.49 to 32.78
(p < 0.001) (not tabulated). From T1
to T2, mean CAL did not change
significantly in either smokers or
non-smokers (not tabulated).
An overall distribution of
PD ≥ 5 mm with BoP was 11.3% in
smokers and 7.1% in non-smokers.
In comparison, the corresponding
percentages for PD ≥ 5 mm only
were 14.8% in smokers and 8.3% in
non-smokers. Compared with non-
smokers, smokers had 4.2% more
number of sites with PD ≥ 5 mm
with BoP compared with 6.5% more
PD ≥ 5 mm. The number of sites
with PD ≥ 5 mm with BoP at T0,
T1, and T2 are summarized in
Table 3. At T1, the total number in
smokers were 132 (2.6%) and 52
(1.0%) in non-smokers (p < 0.001),
increasing at T2 to 180 (3.8%) in
smokers and 79 (1.6%) in non-smo-
kers (p < 0.001). From T1 to T2, the
increase was significant for all teeth
and sites in smokers and non-smo-
kers, except for multi-rooted buccal
sites in non-smokers. At T2, a higher
number of PD ≥ 5 mm with BoP
was observed in smokers compared
with non-smokers at maxillary molar
palatal sites (p = 0.040), at maxillary
single-rooted palatal and buccal sites
(p = 0.001 and p = 0.002, respec-
tively), and at mandibular single-
rooted lingual sites (p = 0.032).
Based on the number of
PD ≥ 5 mm with BoP, patients were
allocated into four different groups:
(1) patients with 0 sites; (2) patients
with 1–4 sites; (3) patients with 5-8
sites; and (4) patients with ≥9 sites.
For both smokers and non-smokers
at T0, 97.5% (n = 39) had ≥9 sites
and 2.5% (n = 1) 5-8 sites. For
smokers at T1, 13.2% (n = 5) had
≥9 sites, 13.2% (n = 5) 5-8 sites,
55.3% (n = 21) 1–4 sites, and 18.4%
(n = 7) had 0 numbers of
PD ≥ 5 mm with BoP (not tabu-
lated). At T2, the corresponding per-
centages were 16.7% (n = 6), 25.0%
(n = 9), 38.9% (n = 14), and 19.4%
(n = 7). For non-smokers at T1, 0
patients had ≥9 sites (group 4) and
8.1% (n = 3) had 5-8 sites (group 3)
and at T2, the respective percentages
were 2.8% (n = 1) and 13.9%
(n = 5). The mean level of three dif-
ferent cigarette measures was
recorded and presented for each
patient group at T0 and T2 (Fig. 2).
Compared with subjectively reported
Active (T0 -T1) and supportive (T1-T2) periodontal therapy
Dropouts
n= 5
Lost to follow-up (compliance) 
n = 1 non-smoker
Discontinued intervention 
(systemic antibiotic)
n = 4 (2 smokers, 2 non-smokers)
T0 
n = 80 (40 smokers, 40 non-smokers)
T1 
n = 75 (38 smokers, 37 non-smokers)
Dropouts
n = 3
Lost to follow-up 
n = 1 smoker (compliance)
n = 1 non-smoker (deceased)
Discontinued intervention (systemic 
antibiotic and compliance)
n = 1 smoker
T2
n = 72 (36 smokers, 36 non-smokers)
Extracted teeth
n = 48 (37 smokers, 11 non-smokers
Extracted teeth
n = 7 (4 smokers,3 non-smokers)
Fig. 1. Study flow chart.
Table 2. Patient-related clinical measures in smokers and non-smokers at T0, T1, and T2
Clinical
measures
















23.35 (5.14) 25.08 (2.88) 0.069 22.53 (5.65) 24.81 (3.30) 0.036 22.11 (6.24) 24.61 (3.15) 0.058
PD 3.80 (1.63) 3.36 (1.52) <0.001 2.63 (1.02) 2.27 (0.85) <0.001 2.80 (1.11) 2.42 (0.88) <0.001
CAL 4.55 (1.80) 3.97 (1.48) 0.001 3.57 (1.34) 3.06 (1.12) <0.001 3.60 (1.52) 3.13 (1.11) <0.001
BI 66.68 (17.93) 67.33 (15.57) 0.864 22.42 (8.41) 22.81 (10.97) 0.864 27.00 (8.02) 30.50 (9.78) 0.050
PI 54.62 (21.72) 54.63 (21.72) 0.607 18.45 (10.89) 21.49 (14.13) 0.304 30.09 (16.14) 32.78 (14.59) 0.352
BI, bleeding index; CAL, clinical attachment level; SEM, standard error of the mean, PD, probing depth; PI, plaque index.
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consumption, the serum cotinine
levels were higher for smokers pre-
senting ≥9 sites with PD ≥ 5 mm
with BoP at T2. For this group, the
objectively validated cigarette con-
sumption showed 37.9% higher
mean serum cotinine level at T2
(697 ng/ml) compared with the mean
serum cotinine level in the groups
presenting a lower number of
PD ≥ 5 mm with BoP (433 ng/ml).
At the site level, clinical parame-
ters and numbers of teeth at T0 and
T1 were tested in smokers and non-
smokers as predictors for
PD ≥ 5 mm with BoP at T2
(Table 4). All variables significantly
increased the OR, except for number
of teeth at T0 and T1 and for plaque
positive sites at T0 in smokers. BoP
at T0 was a strong predictor in
smokers (OR: 8.93, CI: 3.28, 24.36,
p < 0.001) and non-smokers (OR:
10.99, CI: 3.33, 36.23 p < 0.001).
Compared with BoP at T0, BoP at
T1 increased the OR in smokers
(OR = 13.26, CI: 5.12, 34.38,
p < 0.001), but not in non-smokers
(OR = 4.68, CI: 1.32, 16.61, p <
0.001). Plaque positive sites at T0
predicted PD ≥ 5 mm with BoP only
in non-smokers (OR = 3.05, CI:
1.19, 7.82, p = 0.020), whereas an
association was revealed between
plaque positive sites at T1 in smok-
ers (OR = 5.83, CI: 2.74, 12.42,
p < 0.001) and non-smokers (OR =
2.29, CI: 1.03, 5.07, p < 0.041).
The overall effect of smoking at
T2 on the number of sites with
PD ≥ 5 mm and BoP was tested at
different teeth and sites using adjusted
logistic regression analysis (Table 5).
An overall negative effect of smoking
was demonstrated (OR = 2.78, CI:
1.49, 5.18, p = 0.001) particularly at
maxillary single-rooted buccal and
palatal sites (OR = 6.21, CI: 2.05,
18.88, p = 0.001 and OR = 4.55, CI:
1.61, 12.85, p = 0.004 respectively),
mandibular single-rooted buccal sites
(OR = 4.35, CI: 1.06, 17.82,
p = 0.041), and mandibular multi-
rooted buccal sites (OR = 4.10, CI:
1.09, 15.38, p = 0.036). The overall
ICC were reported within patients
(ICC = 0.114), teeth (ICC = 0.509),
and sites (ICC = 0.761). The variation
was highest at the patient level and
least at the site level and was consis-
tent within different teeth and sites
(Table 5). At the patient level, the
overall ICC for smokers
(ICC = 0.137) was higher than for
non-smokers (ICC = 0.051; not tabu-
lated).
Discussion
The present study evaluated the
effect of cigarette smoking at
patient, tooth, and site levels follow-
ing 12 months of SPT. During SPT,
smokers and non-smokers presented
increased numbers of PD ≥ 5 mm
with BoP with the greatest increase
at maxillary single-rooted teeth in
smokers; from 10 to 16 at buccal
sites and from 25 to 48 at palatal
sites. An overall negative effect of
smoking was revealed at T2 with the
strongest effect at maxillary single-
rooted teeth. To a great extent, the
site-specific effects explain the out-
comes of periodontal therapy
(D’Aiuto et al. 2005) and the
patient-related effect of smoking
seems to act as a modifier at the
Table 3. Numbers of sites with probing depth ≥5 mm with BoP before (T0), following active (T1), and supportive periodontal therapy (T2)
at arch and tooth level














Overall 1471 (26.4) 1049 (17.5) <0.001 132 (2.6) 52 (1.0) <0.001 180 (3.8) 79 (1.6) 0.001
Maxillary multi-rooted
Buccal 131 (39.7) 136 (32.6) 0.105 10 (3.8) 7 (2.0) 0.209 11 (3.6) 12 (4.6) 0.731
Palatal 175 (53.0) 198 (47.5) 0.309 27 (10.2) 15 (4.2) 0.009 31 (12.0) 21 (6.4) 0.040
Maxillary single-rooted
Buccal 214 (20.8) 124 (11.2) 0.680 16 (1.7) 2 (0.2) 0.121 26 (2.9) 6 (0.6) 0.002
Palatal 374 (46.4) 180 (16.2) 0.030 25 (2.6) 8 (0.8) 0.159 48 (5.4) 12 (1.3) 0.001
Mandibulary multi-rooted
Buccal 99 (33.0) 86 (24.9) 0.269 9 (3.0) 7 (2.3) 0.617 10 (3.4) 3 (1.1) 0.055
Lingual 137 (41.5) 125 (36.2) 0.326 12 (4.0) 9 (2.9) 0.561 17 (5.7) 12 (4.2) 0.473
Mandibulary single-rooted
Buccal 154 (14.1) 95 (8.4) 0.148 14 (1.4) 2 (0.2) 0.628 21 (2.2) 5 (0.5) 0.164
Lingual 187 (17.1) 105 (9.3) 0.011 19 (1.9) 2 (0.2) 0.190 16 (1.7) 8 (0.8) 0.032
BoP; bleeding on probing; multi-rooted, molars; single-rooted, premolars and incisors; buccal, two proximal-buccal and one mid-buccal;

























































Fig. 2. Means of smoking measures in
patients with 0, 1–4, 5–8, and ≥9 sites of
probing depth ≥5 mm and bleeding on
probing at T0 and T2.
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site-specific level. As suggested, the
magnitude of changes during SPT
appears related to the initial defect
size at site level and to heavy smok-
ing at patient level (Matuliene et al.
2008). Moreover, a local effect of
smoking appears to be superimposed
on the systemic effect, particularly
affecting maxillary single-rooted
teeth. In smokers, the percentage of
PD ≥ 5 mm with BoP at these teeth
increased from 31% at T1 to 41% at
T2, whereas the percentage for max-
illary multi-rooted teeth declined
from 28% to 23%, respectively. The
percentage at T2 were comparable
with baseline registration and in
accordance with previous findings
demonstrating a high percentage of
PD ≥ 5 mm in single-rooted teeth in
smokers (van der Weijden et al.
2001). Interestingly, the results show
slightly different site-specific treat-
ment outcomes following APT and
SPT, indicating altered local tissue
responses to cigarette smoking dur-
ing APT compared with SPT.
Including BoP in the primary
outcome variable could introduce a
bias due to less BoP in smokers
compared with non-smokers (Preber
& Bergstr€om 1985, Bergstr€om &
Bostr€om 2001). On the other hand, a
site level periodontal diagnose
including BoP seems to correlate
with disease progression and
periodontal instability irrespective of
smoking status (Ramseier et al.
2015). At a site level, absence of
BoP is considered to predict long-
term stability following treatment of
chronic periodontitis patients (Lang
et al. 1990), whereas presence of
BoP predicts disease progression in
both smokers and non-smokers
(Ramseier et al. 2015). However, it
is not clear whether BoP to the same
extent is associated with disease pro-
gression at a site level in smokers
and non-smokers. In this study, the
association between BoP at T1 and
PD ≥ 5 mm with BoP at T2 was
stronger in smokers compared with
non-smokers. More intense bleeding
from deep pockets following non-
surgical periodontal therapy in
smokers (Ardais et al. 2014) can be
explained by a hyper-inflammatory
condition in gingival tissues, thus
making BoP a strong predictor for
disease progression during SPT.
A tendency towards recurrence of
periodontitis during SPT was sup-
ported by a significant increase in
PD, BI, and PI in both smokers and
non-smokers. These findings are in
agreement with previous studies
showing a slight disease progression
during the first years following ATP
(Knowles et al. 1979, Preshaw &
Heasman 2005). These longitudinal
trends of treatment progression
might reflect lack of compliance
from highly susceptible patients dur-
ing the first years of SPT. In this
study, to compensate for variation in
compliance among smokers
Table 4. Clinical parameters and number of teeth as predictors for probing depth (PD) ≥ 5 mm with bleeding on probing (BoP) at T2 in
smokers and non-smokers
Smokers Non-smokers
OR (95% CI)a p OR (95% CI)a p
T0
Teeth 1.02 (0.94, 1.10) 0.699 1.16 (1.01, 1.34) 0.035
CAL 1.48 (1.19, 1.83) <0.001 1.63 (1.32, 2.02) <0.001
PD 2.12 (1.74, 2.59) <0.001 2.25 (1.68, 3.01) <0.001
BoP 8.93 (3.28, 24.36) <0.001 10.99 (3.33, 36.23) <0.001
Plaque 2.21 (0.70, 6.36) 0.185 3.05 (1.19, 7.82) 0.020
T1
Teeth 1.03 (0.94, 1.12) 0.527 1.16 (1.03, 1.31) 0.017
CAL 2.25 (1.80, 2.82) <0.001 2.81 (2.14, 3.67) <0.001
PD 5.63 (3.46, 9.16) <0.001 7.39 (4.25, 12.85) <0.001
BoP 13.26 (5.12, 34.38) <0.001 4.68 (1.32, 16.61) <0.001
Plaque 5.83 (2.74, 12.42) <0.001 2.29 (1.03, 5.07) 0.041
T0-T2, baseline before active periodontal therapy (T0)-12 months of supportive periodontal therapy (T2), T1-T2; following completion of
active periodontal therapy (T1)-12 months with supportive periodontal therapy (T2).
aLogistic regression showing effect of tooth and site-related conditions at T0 and at T1 adjusted for gender, age, marital status, and education.
Table 5. The effect of smoking on probing depth ≥5 mm with bleeding on probing at T2
presented with intra-class correlation coefficients (ICC) within patients, teeth, and sites
OR (95% CI) p ICCa ICCb ICCc
Overall 2.78 (1.49, 5.18) 0.001 0.114 0.509 0.761
Maxillary multi-rooted 1.55 (0.74, 3.23) 0.238 0.165 0.472 0.758
Buccal sites 1.12 (0.46, 2.75) 0.802 0.161 0.286 0.686
Palatal sites 1.81 (0.84, 3.88) 0.129 0.182 0.371 0.746
Maxillary single-rooted 5.08 (2.01, 12.78) 0.001 0.184 0.476 0.752
Buccal sites 6.21 (2.05, 18.88) 0.001 0.156 0.351 0.754
Palatal sites 4.55 (1.61, 12.85) 0.004 0.210 0.406 0.733
Mandibular multi-rooted 2.51 (1.01, 6.23) 0.047 0.163 0.355 0.691
Buccal sites 4.10 (1.09, 15.38) 0.036 na 0.117 0.746
Lingual sites 2.12 (0.82, 5.49) 0.120 0.168 0.231 0.642
Mandibular single-rooted 3.09 (1.01, 9.43) 0.048 0.171 0.575 0.763
Buccal sites 2.34 (0.75, 7.26) 0.143 0.257 0.401 0.755
Lingual sites 4.35 (1.06, 17.82) 0.041 0.136 0.664 0.781
Logistic regression showing main effect of patient-related conditions at T2 adjusted for gen-
der, age, marital status, and education.
aICC, intra-class correlation coefficients within patients.
bICC, intra-class correlation coefficients within teeth.
cICC, intra-class correlation coefficients within sites na; not available.
© 2016 The Authors. Journal of Clinical Periodontology Published by John Wiley & Sons Ltd.
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(Ramseier et al. 2014), a 3-month
SPT frequency compatible with
maintenance of highly susceptible
patients, was offered. Preferably, the
frequency of SPT should reflect the
individual risk profile. However, in
this prospective study, the SPT inter-
val was standardized regardless of
the susceptibility for recurrence of
periodontitis, and patients exceeding
a 4-month interval were excluded.
The effort to adjust for compliance
should be considered a merit in the
analyses of evaluating the effect of
smoking exposure on the efficacy of
SPT.
The exposure of smoking was
quantified and objectively validated
by measuring serum cotinine concen-
tration. At T2, an association was
revealed between ≥9 sites of
PD ≥ 5 mm with BoP per patient
and high cotinine levels. Heavy
smoking during periodontal treat-
ment, quantified by high levels of
cotinine, negatively influenced the
outcome of SPT. This association
was not detected at T0, indicating
that doses of current smoking expo-
sure do not to the same extent influ-
ence the level of periodontal disease.
Consequently, when smoking cessa-
tion is not successful, reduced smok-
ing exposure during therapy should
be encouraged. A dose-related treat-
ment response has been documented
(Kaldahl et al. 1996a), however, not
by objective measures of smoking
exposure during therapy. In this
study, 86% of the patients with ≥9
sites of PD ≥ 5 mm with BoP at T2
were heavy smokers. These findings
are in agreement with a former study
concluding that 90% of non-respon-
ders are smokers (Magnusson &
Walker 1996). Non-responding peri-
odontitis, characterized by multiple
progressing sites following therapy,
is considered a patient-specific more
than site-specific entity. Smoking as
a patient-related risk factor has pre-
viously been recognized (Kornman
et al. 1997, Matuliene et al. 2010)
and in this study, smoking out-
weighed other patient-related risk
factors documented by a smaller
variation in PD ≥ 5 mm with BoP at
T2 within smokers compared with
non-smokers.
A few limitations of this study,
however, should be discussed. The
lack of masking has been addressed
previously (Bunæs et al. 2015).
Further, a follow-up period of
12 months is a relatively short time
to study the effect of smoking on
the outcome of SPT. An extension
of the observation period might pro-
vide more substantiated information.
On the other hand, during a longer
follow-up period, more patients are
prone to drop out and a higher
number of smokers might quit
smoking. Both factors could defi-
nitely have undermined the statisti-
cal analysis and the validity of the
results. Three smokers reported
smoking cessation between T1 and
T2 and yet were not excluded from
the study. Matching serum cotinine
concentration confirmed smoking
cessation for one, whereas the other
two reported the use of snuff to sub-
stitute cigarette nicotine. In Scandi-
navia, the use of snuff has increased
significantly during recent years,
especially among adolescents (Her-
gens et al. 2014). Unregistered use
of snuff may have disturbed the
measured cotinine concentrations in
serum and might be considered a
confounder.
In summary, both smokers and
non-smokers showed a slight recur-
rence of disease following
12 months of SPT. However, both
smokers and non-smokers
responded to periodontal therapy
with significant reductions in mean
PD, CAL, BI, and PI (p < 0.001).
An overall negative effect of smok-
ing on PD ≥ 5 mm with BoP was
demonstrated with a site-specific tis-
sue response to smoking. Further,
BoP at T1 in smokers was a strong
site-specific predictor for
PD ≥ 5 mm with BoP at T2. At the
patient level, elevated cotinine mea-
sures at T2 were associated with ≥9
sites of PD ≥ 5 mm with BoP. The
study reveals that cigarette smoking
as a patient-related risk factor may
modulate site-associated variables
affecting outcomes of SPT. The
magnitude of the effect of cigarette
smoking on local tissue responses
should be further explored in
prospective studies with objective
quantification of smoking exposure.
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Scientific rationale for the study: In
general, smokers respond less
favourably to periodontal therapy
compared with non-smokers. To
predict the long-term outcome of
periodontal therapy in smokers,
the effect of smoking needs to be
evaluated at patient, tooth, and site
level following active therapy.
Principal findings: An overall nega-
tive effect of smoking was demon-
strated following 12 months of
supportive periodontal therapy,
especially at maxillary single-rooted
teeth. At patient level, high serum
cotinine levels were associated with
≥9 disease progressing sites. At site
level, bleeding on probing following
active periodontal therapy predicted
an increased risk of disease pro-
gression in smokers compared with
non-smokers.
Practical implications: In perspec-
tive, smoking cessation or even
smoking reduction may benefit
treatment outcomes following sup-
portive periodontal therapy.
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